Renu Eapen
Papers
2
Total Citations
91
H-Index
2
About
Renu Eapen is a leading urological surgeon and researcher whose work focuses on advancing treatment for prostate cancer, particularly through innovative surgical and therapeutic approaches. Her major contributions center on the integration of targeted radionuclide therapy with radical prostatectomy, most notably as a principal investigator in the landmark LuTectomy trial. This single-centre, phase 1/2 study (2023, 84 citations) demonstrated the safety and feasibility of administering [177Lu]Lu-PSMA-617 prior to radical prostatectomy in men with high-risk localized prostate cancer—a pioneering approach that bridges nuclear medicine and surgical oncology. Additionally, Eapen has critically evaluated perioperative practices, such as in her review on prophylactic drain tube use post-robot-assisted radical prostatectomy (2020, 7 citations), challenging surgical dogma and promoting evidence-based care. Her work has significant impact, with the LuTectomy study already shaping clinical protocols and inspiring further research into neoadjuvant theranostic strategies. Eapen’s achievements include advancing personalized treatment for high-risk prostate cancer patients, and her research continues to influence both surgical technique and multidisciplinary management of the disease.
Research Focus
Key Achievements
Top Papers
- 1
- 2